TTM
$0.00
YoY change
-100.0%
5Y CAGR
—
Peak year (2023)
$10.09M
Cumulative gross profit
$14.99M
Gross Profit history chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: $0.00
Gross Profit growth chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: -100.0%
Gross Profit history table for Spruce Biosciences (SPRB) from 2018 to 2025
| 2025 | $0.00 | -100.0% | −$4.91M | ||
| 2024 | $4.91M | -51.3% | −$5.18M | ||
| 2023 | $10.09M | — | +$10.09M | ||
| 2022 | $0.00 | — | $0.00 | ||
| 2021 | $0.00 | — | $0.00 | ||
| 2020 | $0.00 | -100.0% | +$12.00K | ||
| 2019 | −$12.00K | +1100.0% | −$11.00K | ||
| 2018 | −$1.00K | — | — |
- 2025$0.00-100.0%
- 2024$4.91M-51.3%
- 2023$10.09M—
- 2022$0.00—
- 2021$0.00—
- 2020$0.00-100.0%
- 2019−$12.00K+1100.0%
- 2018−$1.00K—
Gross Profit values are taken from Spruce Biosciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Spruce Biosciences (SPRB)
According to Spruce Biosciences's latest reported financial statements, the company's current gross profit (TTM) is $0.00. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Spruce Biosciences (SPRB) reported gross profit of $0.00 – plunged 100.0% year-over-year.
Between 2023 and 2025, Spruce Biosciences gross profit plunged 100.0%, falling from $10.09M to $0.00.
2023 marks the peak gross profit at $10.09M, with the historical low of −$12.00K recorded in 2019.
Spruce Biosciences Gross Profit by Year
Spruce Biosciences Gross Profit 2025: $0.00
2025's gross profit for Spruce Biosciences came in at $0.00, plunged 100.0% below 2024.
Spruce Biosciences Gross Profit 2024: $4.91M
Spruce Biosciences posted gross profit of $4.91M in 2024, plunged 51.3% below 2023.
Spruce Biosciences Gross Profit 2023: $10.09M
Spruce Biosciences gross profit in 2023 was $10.09M.
Spruce Biosciences Gross Profit 2022: $0.00
Spruce Biosciences gross profit in 2022 was $0.00.
Spruce Biosciences Gross Profit 2021: $0.00
Spruce Biosciences gross profit in 2021 was $0.00.
See more financial history for Spruce Biosciences (SPRB).
Sector peers by Gross Profit
Healthcare peers of Spruce Biosciences (SPRB), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation